Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;14(3):601-11.
doi: 10.1208/s12248-012-9373-2. Epub 2012 May 31.

Performance of methods for handling missing categorical covariate data in population pharmacokinetic analyses

Affiliations

Performance of methods for handling missing categorical covariate data in population pharmacokinetic analyses

Ron J Keizer et al. AAPS J. 2012 Sep.

Abstract

In population pharmacokinetic analyses, missing categorical data are often encountered. We evaluated several methods of performing covariate analyses with partially missing categorical covariate data. Missing data methods consisted of discarding data (DROP), additional effect parameter for the group with missing data (EXTRA), and mixture methods in which the mixing probability was fixed to the observed fraction of categories (MIX(obs)), based on the likelihood of the concentration data (MIX(conc)), or combined likelihood of observed covariate data and concentration data (MIX(joint)). Simulations were implemented to study bias and imprecision of the methods in datasets with equal-sized and unbalanced category ratios for a binary covariate as well as datasets with non-random missingness (MNAR). Additionally, the performance and feasibility of implementation was assessed in two real datasets. At either low (10%) or high (50%) levels of missingness, all methods performed similarly well. Performance was similar for situations with unbalanced datasets (3:1 covariate distribution) and balanced datasets. In the MNAR scenario, the MIX methods showed a higher bias in the estimation of CL and covariate effect than EXTRA. All methods could be applied to real datasets, except DROP. All methods perform similarly at the studied levels of missingness, but the DROP and EXTRA methods provided less bias than the mixture methods in the case of MNAR. However, EXTRA was associated with inflated type I error rates of covariate selection, while DROP handled data inefficiently.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Dataset designs used in the simulation analysis. Black indicates the fraction of male subjects; white indicates females. Left part shows the observed covariate data and right part (grayed out) shows the missing part. Missingness percentage in observed population given between brackets. NonRand probability of missing is 25% for females and 75% for males
Fig. 2
Fig. 2
Distribution of bias in CL, balanced dataset. Numbers in the bottom indicate RMSE
Fig. 3
Fig. 3
Distribution of bias in covariate effect, balanced dataset. Numbers in the bottom indicate RMSE
Fig. 4
Fig. 4
Estimated p mix, balanced dataset
Fig. 5
Fig. 5
“NonRand” dataset: bias in CL (left) and covariate effect size (right)
Fig. 6
Fig. 6
Distribution of bias in covariate effect for the datasets with time-varying covariates for MCAR (left) and MNAR (right) scenarios

References

    1. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77. doi: 10.1037/1082-989X.7.2.147. - DOI - PubMed
    1. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2008;60:549–76. doi: 10.1146/annurev.psych.58.110405.085530. - DOI - PubMed
    1. Bosch TM, Huitema ADR, Doodeman VD, et al. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin Cancer Res. 2006;12(19):5786–93. doi: 10.1158/1078-0432.CCR-05-2649. - DOI - PubMed
    1. de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals. Br J Clin Pharmacol. 2002;54(4):378–85. doi: 10.1046/j.1365-2125.2002.01657.x. - DOI - PMC - PubMed
    1. Joerger M, Huitema ADR, van den Bongard D, Schellens JHM, Beijnen JH. Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors. Clin Cancer Res. 2006;12(7 Pt 1):2150–7. doi: 10.1158/1078-0432.CCR-05-2069. - DOI - PubMed

LinkOut - more resources